In this video, Motley Fool health-care analyst David Williamson discusses what investors should look for in�Biogen Idec's upcoming earnings report, and what the Big Biotech has in store for 2013.
The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in our brand-new free report: "The Motley Fool's Top Stock for 2013." Grab a free copy for a limited time. Just click here to access the report and find out the name of this under-the-radar company.
�
�
No comments:
Post a Comment